» Articles » PMID: 8410188

Purification and Properties of M1-toxin, a Specific Antagonist of M1 Muscarinic Receptors

Overview
Journal J Neurosci
Specialty Neurology
Date 1993 Oct 1
PMID 8410188
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The venom of the Eastern green mamba from Africa, Dendroaspis angusticeps, was found to block the binding of 3H-quinuclidinyl benzilate to pure m1 and m4 muscarinic ACh receptors expressed in Chinese hamster ovary cells. The principal toxin in the venom with anti-m1 muscarinic activity was purified by gel filtration and reversed-phase HPLC. This toxin has 64 amino acids, a molecular mass of 7361 Da, and an isoelectric point of 7.04. Its cysteine residues are homologous with those in curare-mimetic alpha-neurotoxins, and with those in fasciculin, which inhibits AChE. At low concentrations the toxin blocked m1 receptors fully and pseudoirreversibly while having no antagonist activity on m2-m5 receptors; the toxin is therefore named "m1-toxin." At higher concentrations m1-toxin interacted reversibly with m4 receptors, and half of the toxin dissociated in 20 min at 25 degrees C. The affinity of m1-toxin is therefore much higher for m1 than for m4 receptors. By comparison with m1-toxin, pirenzepine has sixfold higher affinity for m1 than for m4 receptors. Autoradiographs of muscarinic receptors in the rat brain demonstrated that m1-toxin blocked the binding of 2 nM 3H-pirenzepine only in regions known to bind m1-specific antibodies. Thus, m1-toxin is a much more selective ligand than pirenzepine for functional and binding studies of m1 muscarinic receptors.

Citing Articles

Muscarinic acetylcholine type 1 receptor antagonism activates TRPM3 to augment mitochondrial function and drive axonal repair in adult sensory neurons.

Chauhan S, Smith D, Shariati-Ievari S, Srivastava A, Dhingra S, Aliani M Mol Metab. 2024; 92:102083.

PMID: 39694091 PMC: 11732569. DOI: 10.1016/j.molmet.2024.102083.


Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.

Poon M, Lorrain K, Stebbins K, Edu G, Broadhead A, Lorenzana A Proc Natl Acad Sci U S A. 2024; 121(32):e2407974121.

PMID: 39083422 PMC: 11317586. DOI: 10.1073/pnas.2407974121.


Antagonism of the Muscarinic Acetylcholine Type 1 Receptor Enhances Mitochondrial Membrane Potential and Expression of Respiratory Chain Components via AMPK in Human Neuroblastoma SH-SY5Y Cells and Primary Neurons.

Naznin F, Waise T, Fernyhough P Mol Neurobiol. 2022; 59(11):6754-6770.

PMID: 36002781 PMC: 9525428. DOI: 10.1007/s12035-022-03003-1.


Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.

Van Baelen A, Robin P, Kessler P, Maiga A, Gilles N, Servent D Front Mol Biosci. 2022; 9:811365.

PMID: 35198603 PMC: 8859281. DOI: 10.3389/fmolb.2022.811365.


Structure and selectivity engineering of the M muscarinic receptor toxin complex.

Maeda S, Xu J, N Kadji F, Clark M, Zhao J, Tsutsumi N Science. 2020; 369(6500):161-167.

PMID: 32646996 PMC: 7954660. DOI: 10.1126/science.aax2517.